Demetrius Klee Lopes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Demetrius Klee Lopes has a total of 298 co-authors. Here are the top co-authors by number of shared publications:
- Peter Kan
Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA
13 shared publications - Adnan H. Siddiqui
Department of Neurosurgery, State University of New York at Buffalo, Buffalo, New York, USA
12 shared publications - Ajith J. Thomas
Department of Neurosurgery, Cooper University Health Care, Camden, New Jersey, USA
10 shared publications - Elad I. Levy
Department of Neurosurgery, State University of New York at Buffalo, Buffalo, New York, USA
10 shared publications - Giuseppe Lanzino
Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA
10 shared publications - J. Mocco
The Mount Sinai Health System, New York, New York, USA
10 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (4)
Initial Experience With a Deep Learning Algorithm for Detecting Posterior Circulation Large Vessel Occlusion on Noncontrast Computed Tomography
BACKGROUND: Detection of large vessel occlusions using a deep learning (DL) algorithm for the anterior circulation has shown promising results. However, the role of DL algorithms in detecting posterior circulation large vessel occlusion (PC-LVO) remains uncertain. We aimed to evaluate the diagnostic performance of a DL algorithm (Methinks PC-LVO) for detecting PC-LVO using noncontrast computed tomography. METHODS: This is a retrospective, multicenter, observational cohort study that included patients with PC-LVO who underwent both noncontrast computed tomography and computed tomography angiography. The diagnostic performance of the DL algorithm was assessed by analyzing sensitivity, specificity, and area under the curve for PC-LVO detection of consecutive PC-LVO strokes. For comparative analysis, the area under the curve of the DL algorithm was also evaluated against the performance of a neuroradiologist interpreting noncontrast computed tomography. Ground truth labels were established through consensus readings by expert neuroradiologists. Subgroup analyses were performed according to clot location (proximal posterior cerebral artery and basilar artery) and National Institutes of Health Stroke Scale (NIHSS) score (NIHSS score ≥6, NIHSS score ≥8, and NIHSS score ≥10). RESULTS: A total of 196 patients were included, of whom 74 patients had PC-LVO. Among these, 43 had basilar artery occlusions, and 34 had proximal posterior cerebral artery occlusions. The overall sensitivity and specificity of the software were 55.4% and 80.9%, respectively, with an area under the curve of 0.72. The neuroradiologist achieved a sensitivity of 27.4% and specificity of 91.8%. Among patients with proximal posterior cerebral artery occlusion, sensitivity was 55.9%, whereas for basilar artery occlusion, it was 53.5%. When stratified by NIHSS score ≥10, sensitivity in the proximal posterior cerebral artery was 56.2%, and for the basilar artery with NIHSS score ≥10, it increased to 61.5%. CONCLUSIONS: Our initial experience with a DL algorithm for the detection of PC-LVO showed promising results. However, further improvements are required before the algorithm can be implemented in clinical practice.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (4)
Open AccessInitial Experience With a Deep Learning Algorithm for Detecting Posterior Circulation Large Vessel Occlusion on Noncontrast Computed Tomography
BACKGROUND: Detection of large vessel occlusions using a deep learning (DL) algorithm for the anterior circulation has shown promising results. However, the role of DL algorithms in detecting posterior circulation large vessel occlusion (PC-LVO) remains uncertain. We aimed to evaluate the diagnostic performance of a DL algorithm (Methinks PC-LVO) for detecting PC-LVO using noncontrast computed tomography. METHODS: This is a retrospective, multicenter, observational cohort study that included patients with PC-LVO who underwent both noncontrast computed tomography and computed tomography angiography. The diagnostic performance of the DL algorithm was assessed by analyzing sensitivity, specificity, and area under the curve for PC-LVO detection of consecutive PC-LVO strokes. For comparative analysis, the area under the curve of the DL algorithm was also evaluated against the performance of a neuroradiologist interpreting noncontrast computed tomography. Ground truth labels were established through consensus readings by expert neuroradiologists. Subgroup analyses were performed according to clot location (proximal posterior cerebral artery and basilar artery) and National Institutes of Health Stroke Scale (NIHSS) score (NIHSS score ≥6, NIHSS score ≥8, and NIHSS score ≥10). RESULTS: A total of 196 patients were included, of whom 74 patients had PC-LVO. Among these, 43 had basilar artery occlusions, and 34 had proximal posterior cerebral artery occlusions. The overall sensitivity and specificity of the software were 55.4% and 80.9%, respectively, with an area under the curve of 0.72. The neuroradiologist achieved a sensitivity of 27.4% and specificity of 91.8%. Among patients with proximal posterior cerebral artery occlusion, sensitivity was 55.9%, whereas for basilar artery occlusion, it was 53.5%. When stratified by NIHSS score ≥10, sensitivity in the proximal posterior cerebral artery was 56.2%, and for the basilar artery with NIHSS score ≥10, it increased to 61.5%. CONCLUSIONS: Our initial experience with a DL algorithm for the detection of PC-LVO showed promising results. However, further improvements are required before the algorithm can be implemented in clinical practice.
- Open Access
- 30 January 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Post-approval study 3-year outcomes of the Neuroform Atlas stent for the treatment of wide-necked intracranial aneurysms
Introduction: The ATLAS trial was a prospective, multicenter, single-arm, investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Neuroform Atlas Stent System for the treatment of wide-necked bifurcation aneurysms. This analysis presents the 36-month follow-up data for the anterior and posterior cohorts. Methods: Of the 182 patients in the IDE anterior cohort, 146 consented to participate in the post-approval study (PAS) and, of the 116 patients in the IDE posterior cohort, 101 consented to participate in the PAS. The primary effectiveness endpoint was core laboratory adjudicated (Raymond–Roy 1; RR1) without retreatment or parent artery stenosis (>50%) at 36 months post-procedure. The primary safety endpoint was Clinical Event Committee-adjudicated major ipsilateral stroke or neurological death through 36 months. Results: There were 146 patients in the anterior cohort and 101 patients in the posterior cohort. At 24 months the composite effectiveness endpoint was 77.3% (34/44) in the anterior cohort and 65.5% (19/29) in the posterior cohort and at 36 months these rates were 92.3% (24/26) and 75.0% (18/24), respectively. RR1 rates at 24 months were 84.1% (37/44) in the anterior cohort and 70.0% (21/30) in the posterior cohort; at 36 months they were 96.3% (26/27) and 79.2% (19/24), respectively. By 36 months the primary safety endpoint occurred in 4.1% (6/146) of patients in the anterior cohort and 5.0% (5/101) in the posterior cohort. Conclusion: The results of the long-term assessment of the Neuroform Atlas Stent System demonstrate favorable safety and effectiveness in the treatment of wide-necked bifurcation aneurysms without a single treated target aneurysm rupture beyond 12 months post-procedure.
- 30 January 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Open AccessPost-approval study 3-year outcomes of the Neuroform Atlas stent for the treatment of wide-necked intracranial aneurysms
Introduction: The ATLAS trial was a prospective, multicenter, single-arm, investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Neuroform Atlas Stent System for the treatment of wide-necked bifurcation aneurysms. This analysis presents the 36-month follow-up data for the anterior and posterior cohorts. Methods: Of the 182 patients in the IDE anterior cohort, 146 consented to participate in the post-approval study (PAS) and, of the 116 patients in the IDE posterior cohort, 101 consented to participate in the PAS. The primary effectiveness endpoint was core laboratory adjudicated (Raymond–Roy 1; RR1) without retreatment or parent artery stenosis (>50%) at 36 months post-procedure. The primary safety endpoint was Clinical Event Committee-adjudicated major ipsilateral stroke or neurological death through 36 months. Results: There were 146 patients in the anterior cohort and 101 patients in the posterior cohort. At 24 months the composite effectiveness endpoint was 77.3% (34/44) in the anterior cohort and 65.5% (19/29) in the posterior cohort and at 36 months these rates were 92.3% (24/26) and 75.0% (18/24), respectively. RR1 rates at 24 months were 84.1% (37/44) in the anterior cohort and 70.0% (21/30) in the posterior cohort; at 36 months they were 96.3% (26/27) and 79.2% (19/24), respectively. By 36 months the primary safety endpoint occurred in 4.1% (6/146) of patients in the anterior cohort and 5.0% (5/101) in the posterior cohort. Conclusion: The results of the long-term assessment of the Neuroform Atlas Stent System demonstrate favorable safety and effectiveness in the treatment of wide-necked bifurcation aneurysms without a single treated target aneurysm rupture beyond 12 months post-procedure.
- Open Access
- 1 November 2025
- Published by Korean Society of Interventional Neuroradiology in Neurointervention
- Vol. 20 (3) , 180-184
Axillary Artery Access for Neuroendovascular Procedures in Infants: Where to Go When Femoral Puncture Fails?
The femoral artery approach is the primary neuroendovascular access in pediatric patients. However, alternative access sites are sometimes essential. We present the first report of axillary arterial access for neuroendovascular intervention in an infant, and a literature review on pediatric access routes. We present a case of a neonate diagnosed with vein of Galen malformation, with failed canulation of the femoral artery. A right axillary artery access was successfully employed for the intervention. The patient showed improvement and no complications. We demonstrate the feasibility of axillary artery access for neuroendovascular intervention, which may be an alternative for similar challenging cases.
- 1 November 2025
- Published by Korean Society of Interventional Neuroradiology in Neurointervention
- Vol. 20 (3) , 180-184
Open AccessAxillary Artery Access for Neuroendovascular Procedures in Infants: Where to Go When Femoral Puncture Fails?
The femoral artery approach is the primary neuroendovascular access in pediatric patients. However, alternative access sites are sometimes essential. We present the first report of axillary arterial access for neuroendovascular intervention in an infant, and a literature review on pediatric access routes. We present a case of a neonate diagnosed with vein of Galen malformation, with failed canulation of the femoral artery. A right axillary artery access was successfully employed for the intervention. The patient showed improvement and no complications. We demonstrate the feasibility of axillary artery access for neuroendovascular intervention, which may be an alternative for similar challenging cases.
- 17 October 2025
- Published by SAGE Publications in Interventional Neuroradiology
The unseen hands: Elevating neurointerventional education through operator hand visualization
In neurointervention, fluoroscopic images dominate the educational narrative, highlighting device navigation and deployment but neglecting the manual expertise that enables them. The physician's hands, which execute precise torques, tensions, and micro-movements, remain unseen and underappreciated, leaving a critical gap in procedural education. This editorial argues for systematic recording of operator hand movements during neurointerventional procedures and for aligning these recordings with fluoroscopic feeds to create a dual-visual educational resource. Such integration could enhance procedural understanding, improve trainee skill acquisition through direct visual mimicry, and foster more effective case debriefings. We discuss technological feasibility, cost, privacy concerns, and the potential of this approach to standardize and elevate neurointerventional education worldwide. By widening the lens beyond the screen, we can preserve and transmit the tacit manual knowledge that defines procedural mastery.
- 17 October 2025
- Published by SAGE Publications in Interventional Neuroradiology
The unseen hands: Elevating neurointerventional education through operator hand visualization
In neurointervention, fluoroscopic images dominate the educational narrative, highlighting device navigation and deployment but neglecting the manual expertise that enables them. The physician's hands, which execute precise torques, tensions, and micro-movements, remain unseen and underappreciated, leaving a critical gap in procedural education. This editorial argues for systematic recording of operator hand movements during neurointerventional procedures and for aligning these recordings with fluoroscopic feeds to create a dual-visual educational resource. Such integration could enhance procedural understanding, improve trainee skill acquisition through direct visual mimicry, and foster more effective case debriefings. We discuss technological feasibility, cost, privacy concerns, and the potential of this approach to standardize and elevate neurointerventional education worldwide. By widening the lens beyond the screen, we can preserve and transmit the tacit manual knowledge that defines procedural mastery.
- 30 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (5) , 2764-2771
Safety outcomes in endovascular treatment versus best medical management for basilar artery occlusion acute ischemic stroke: A systematic review and meta-analysis of randomized trials
Background: Endovascular therapy (EVT) improves functional outcomes and reduces mortality in acute ischemic stroke (AIS) due to basilar artery occlusion (BAO). However, data on hemorrhagic complications and nonneurologic adverse events remain limited. We conducted a systematic review and meta-analysis to assess these outcomes in randomized controlled trials (RCTs) comparing EVT versus best medical management (BMM). Methods: We searched PubMed, Cochrane Library, and Embase in December 2024 for RCTs comparing EVT and BMM (PROSPERO registry CRD42024617681). Outcomes included any parenchymal hematoma (PH), PH type 1 and 2, subarachnoid hemorrhage (SAH), systemic/extracranial hemorrhage, pneumonia, and heart failure. Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using a random-effects model. Results: Four RCTs, 988 patients (556 EVT, 432 BMM), were included. EVT increased the risk of SAH (RR 5.14; 95% CI [1.35–19.56]; I² = 0.0%) and PH type 2 (RR 5.53; 95% CI [1.47–20.84]; I² = 0.0%) compared to BMM. No significant differences were observed for any PH (RR 1.91; 95% CI [0.92–3.97]; I² = 0.0%), PH type 1 (RR 0.71; 95% CI [0.22–2.29]; I² = 3.4%), systemic/extracranial hemorrhage (RR 1.06; 95% CI [0.71–1.60]; I² = 12.2%), pneumonia (RR 1.00; 95% CI [0.83–1.21]; I² = 0.0%), or heart failure (RR 2.00; 95% CI [0.34–11.92]; I² = 55.4%). Conclusion: In patients with BAO AIS, EVT is associated with an increased risk of SAH and PH type 2 compared with BMM. There was no significant difference in any PH, PH type 1, systemic/extracranial hemorrhage, pneumonia, and heart failure between groups.
- 30 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (5) , 2764-2771
Safety outcomes in endovascular treatment versus best medical management for basilar artery occlusion acute ischemic stroke: A systematic review and meta-analysis of randomized trials
Background: Endovascular therapy (EVT) improves functional outcomes and reduces mortality in acute ischemic stroke (AIS) due to basilar artery occlusion (BAO). However, data on hemorrhagic complications and nonneurologic adverse events remain limited. We conducted a systematic review and meta-analysis to assess these outcomes in randomized controlled trials (RCTs) comparing EVT versus best medical management (BMM). Methods: We searched PubMed, Cochrane Library, and Embase in December 2024 for RCTs comparing EVT and BMM (PROSPERO registry CRD42024617681). Outcomes included any parenchymal hematoma (PH), PH type 1 and 2, subarachnoid hemorrhage (SAH), systemic/extracranial hemorrhage, pneumonia, and heart failure. Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using a random-effects model. Results: Four RCTs, 988 patients (556 EVT, 432 BMM), were included. EVT increased the risk of SAH (RR 5.14; 95% CI [1.35–19.56]; I² = 0.0%) and PH type 2 (RR 5.53; 95% CI [1.47–20.84]; I² = 0.0%) compared to BMM. No significant differences were observed for any PH (RR 1.91; 95% CI [0.92–3.97]; I² = 0.0%), PH type 1 (RR 0.71; 95% CI [0.22–2.29]; I² = 3.4%), systemic/extracranial hemorrhage (RR 1.06; 95% CI [0.71–1.60]; I² = 12.2%), pneumonia (RR 1.00; 95% CI [0.83–1.21]; I² = 0.0%), or heart failure (RR 2.00; 95% CI [0.34–11.92]; I² = 55.4%). Conclusion: In patients with BAO AIS, EVT is associated with an increased risk of SAH and PH type 2 compared with BMM. There was no significant difference in any PH, PH type 1, systemic/extracranial hemorrhage, pneumonia, and heart failure between groups.
- 24 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (5) , 2930-2937
An evidence-based pulsatile tinnitus clinical workflow: A systematic review of literature
Introduction: Endovascular management options for pulsatile tinnitus (PT) patients have increased in recent years with promising results. However, standardized endovascular team referral criteria remain limited. We conducted a systematic review and suggested an evidence-based referral protocol for PT patients to the neuroendovascular team. Methods: A literature review was conducted in February 2025 using the PubMed/MEDLINE database. We included English-written studies published in the last 5 years, focusing on PT diagnosis and management. Exclusion criteria included: (1) in vitro or animal studies, (2) studies focused on open surgery approaches, (3) studies addressing only non-PT, and (4) case reports, case series (3–10 cases), commentaries, letters to the editor, editorials, and book chapters. Results: Our initial search retrieved 257 papers. Of these, 219 were excluded after reading the title and abstract, and an additional 12 were excluded after full-text review. A total of 26 papers were eligible for inclusion in this review and in developing our protocol. After PT diagnosis and imaging, our protocol consists of the following three questions: (1) Is non-invasive imaging suspicious for a dural arteriovenous fistula, high-risk vascular lesions, or idiopathic intracranial hypertension? (2) Despite normal neuroimaging, is there clinical suspicion of a high-risk vascular lesion? (3) Although a low-risk lesion is diagnosed, is PT debilitating? If there is a “yes” to any of these questions, referral to the endovascular team is recommended. Conclusion: We suggested an evidence-based referral protocol for PT patients to the neuroendovascular team.
- 24 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (5) , 2930-2937
An evidence-based pulsatile tinnitus clinical workflow: A systematic review of literature
Introduction: Endovascular management options for pulsatile tinnitus (PT) patients have increased in recent years with promising results. However, standardized endovascular team referral criteria remain limited. We conducted a systematic review and suggested an evidence-based referral protocol for PT patients to the neuroendovascular team. Methods: A literature review was conducted in February 2025 using the PubMed/MEDLINE database. We included English-written studies published in the last 5 years, focusing on PT diagnosis and management. Exclusion criteria included: (1) in vitro or animal studies, (2) studies focused on open surgery approaches, (3) studies addressing only non-PT, and (4) case reports, case series (3–10 cases), commentaries, letters to the editor, editorials, and book chapters. Results: Our initial search retrieved 257 papers. Of these, 219 were excluded after reading the title and abstract, and an additional 12 were excluded after full-text review. A total of 26 papers were eligible for inclusion in this review and in developing our protocol. After PT diagnosis and imaging, our protocol consists of the following three questions: (1) Is non-invasive imaging suspicious for a dural arteriovenous fistula, high-risk vascular lesions, or idiopathic intracranial hypertension? (2) Despite normal neuroimaging, is there clinical suspicion of a high-risk vascular lesion? (3) Although a low-risk lesion is diagnosed, is PT debilitating? If there is a “yes” to any of these questions, referral to the endovascular team is recommended. Conclusion: We suggested an evidence-based referral protocol for PT patients to the neuroendovascular team.
- 6 August 2025
- Published by SAGE Publications in Interventional Neuroradiology
Deployment techniques and crossability of the EVO stent in wide-neck bifurcation aneurysms: An in vitro evaluation
Background: Stent-assisted coiling (SAC) is a well-established technique for treating wide-neck and bifurcation intracranial aneurysms. The second-generation Low-Profile Visualized Intraluminal Support (LVIS) EVO stent offers improved fluoroscopic visibility and deployment control; however, bench data on its performance in complex configurations remains limited. Objective: To evaluate the deployment and crossability of the LVIS EVO stent using shouldering and Y-stenting (crossing and parallel) techniques in a flow model, given their complexity and clinical relevance in the treatment of wide-neck bifurcation aneurysms. Methods: Two silicone basilar tip aneurysm replicas were used in a flow model under physiological conditions. LVIS EVO stents were deployed using the three techniques. A 0.014-inch microwire and 0.017-inch microcatheter were used to assess crossability through inner and outer vessel curvatures. Outcomes included device tracking under fluoroscopy, deployment success, and crossability profile. Results: All stent deployments were technically successful with accurate positioning, excellent fluoroscopic visibility, and no evidence of migration, prolapse, or deformation. Crossability testing confirmed that a 0.017-inch microcatheter and 0.014-inch microwire could be advanced smoothly through both the stent lumen and across the stent walls in all configurations without the need for additional maneuvers. Conclusion: The LVIS EVO stent demonstrated reliable deployment and crossability across complex bifurcation configurations in a flow model. Its radiopacity and flexible design support its use in advanced SAC techniques.
- 6 August 2025
- Published by SAGE Publications in Interventional Neuroradiology
Deployment techniques and crossability of the EVO stent in wide-neck bifurcation aneurysms: An in vitro evaluation
Background: Stent-assisted coiling (SAC) is a well-established technique for treating wide-neck and bifurcation intracranial aneurysms. The second-generation Low-Profile Visualized Intraluminal Support (LVIS) EVO stent offers improved fluoroscopic visibility and deployment control; however, bench data on its performance in complex configurations remains limited. Objective: To evaluate the deployment and crossability of the LVIS EVO stent using shouldering and Y-stenting (crossing and parallel) techniques in a flow model, given their complexity and clinical relevance in the treatment of wide-neck bifurcation aneurysms. Methods: Two silicone basilar tip aneurysm replicas were used in a flow model under physiological conditions. LVIS EVO stents were deployed using the three techniques. A 0.014-inch microwire and 0.017-inch microcatheter were used to assess crossability through inner and outer vessel curvatures. Outcomes included device tracking under fluoroscopy, deployment success, and crossability profile. Results: All stent deployments were technically successful with accurate positioning, excellent fluoroscopic visibility, and no evidence of migration, prolapse, or deformation. Crossability testing confirmed that a 0.017-inch microcatheter and 0.014-inch microwire could be advanced smoothly through both the stent lumen and across the stent walls in all configurations without the need for additional maneuvers. Conclusion: The LVIS EVO stent demonstrated reliable deployment and crossability across complex bifurcation configurations in a flow model. Its radiopacity and flexible design support its use in advanced SAC techniques.
- 25 July 2025
- Published by SAGE Publications in Interventional Neuroradiology
Methinks AI software for identifying large vessel occlusion in non-contrast head CT: A pilot retrospective study in American population
Background: Non-contrast computed tomography (NCCT) is the first image for stroke assessment, but its sensitivity for detecting large vessel occlusion (LVO) is limited. Artificial intelligence (AI) algorithms may contribute to a faster LVO diagnosis using only NCCT. This study evaluates the performance and the potential diagnostic time saving of Methinks LVO AI algorithm in a U.S. multi-facility stroke network. Methods: This retrospective pilot study reviewed NCCT and computed tomography angiography (CTA) images between 2015 and 2023. The Methinks AI algorithm, designed to detect LVOs in the internal carotid artery and middle cerebral artery, was tested for sensitivity, specificity, and predictive values. A neuroradiologist reviewed cases to establish a gold standard. To evaluate potential time saving in workflow, time gaps between NCCT and CTA were analyzed and stratified into four groups in true positive cases: Group 1 (60 min). Results: From a total of 1155 stroke codes, 608 NCCT exams were analyzed. Methinks LVO demonstrated 75% sensitivity and 83% specificity, identifying 146 out of 194 confirmed LVO cases correctly. The PPV of the algorithm was 72%. The NPV was 83% (considering ‘other occlusion’, ‘stenosis’ and ‘posteriors’ as negatives), and 73% considered the same conditions as positives. Among the true positive cases, we found 112 patients Group 1, 32 patients in Group 2, 15 patients in Group 3, 3 patients in Group 4. Conclusion: The Methinks AI algorithm shows promise for improving LVO detection from NCCT, especially in resource limited settings. However, its sensitivity remains lower than CTA-based systems, suggesting the need for further refinement.
- 25 July 2025
- Published by SAGE Publications in Interventional Neuroradiology
Methinks AI software for identifying large vessel occlusion in non-contrast head CT: A pilot retrospective study in American population
Background: Non-contrast computed tomography (NCCT) is the first image for stroke assessment, but its sensitivity for detecting large vessel occlusion (LVO) is limited. Artificial intelligence (AI) algorithms may contribute to a faster LVO diagnosis using only NCCT. This study evaluates the performance and the potential diagnostic time saving of Methinks LVO AI algorithm in a U.S. multi-facility stroke network. Methods: This retrospective pilot study reviewed NCCT and computed tomography angiography (CTA) images between 2015 and 2023. The Methinks AI algorithm, designed to detect LVOs in the internal carotid artery and middle cerebral artery, was tested for sensitivity, specificity, and predictive values. A neuroradiologist reviewed cases to establish a gold standard. To evaluate potential time saving in workflow, time gaps between NCCT and CTA were analyzed and stratified into four groups in true positive cases: Group 1 (60 min). Results: From a total of 1155 stroke codes, 608 NCCT exams were analyzed. Methinks LVO demonstrated 75% sensitivity and 83% specificity, identifying 146 out of 194 confirmed LVO cases correctly. The PPV of the algorithm was 72%. The NPV was 83% (considering ‘other occlusion’, ‘stenosis’ and ‘posteriors’ as negatives), and 73% considered the same conditions as positives. Among the true positive cases, we found 112 patients Group 1, 32 patients in Group 2, 15 patients in Group 3, 3 patients in Group 4. Conclusion: The Methinks AI algorithm shows promise for improving LVO detection from NCCT, especially in resource limited settings. However, its sensitivity remains lower than CTA-based systems, suggesting the need for further refinement.
- 9 May 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 604-605
Simulation of a Remote Robotic Endovascular Thrombectomy
- 9 May 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 604-605
Simulation of a Remote Robotic Endovascular Thrombectomy
- 13 August 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 956-960
Impact of duration of dual anti-platelet therapy on risk of complications after stent-assisted coiling of unruptured aneurysms
Background The optimal duration for dual antiplatelet therapy (DAPT) after stent-assisted coiling (SAC) of intracranial aneurysms is unclear. Longer-term therapy may reduce thrombotic complications but increase the risk of bleeding complications. Methods A retrospective review of prospectively maintained data at 12 institutions was conducted on patients with unruptured intracranial aneurysms who underwent SAC between January 1, 2016 and December 31, 2020, and were followed ≥6 months postprocedure. The type and duration of DAPT, stent(s) used, outcome, length of follow-up, complication rates, and incidence of significant in-stent stenosis (ISS) were collected. Results Of 556 patients reviewed, 450 met all inclusion criteria. Nine patients treated with DAPT 42 days after SAC did not reduce the risk of thrombotic complications or in-stent stenosis, although the risk of additional hemorrhagic complications remained low. It may be reasonable to discontinue DAPT after 42 days following non-flow diverting SAC of unruptured intracranial aneurysms.
- 13 August 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 956-960
Impact of duration of dual anti-platelet therapy on risk of complications after stent-assisted coiling of unruptured aneurysms
Background The optimal duration for dual antiplatelet therapy (DAPT) after stent-assisted coiling (SAC) of intracranial aneurysms is unclear. Longer-term therapy may reduce thrombotic complications but increase the risk of bleeding complications. Methods A retrospective review of prospectively maintained data at 12 institutions was conducted on patients with unruptured intracranial aneurysms who underwent SAC between January 1, 2016 and December 31, 2020, and were followed ≥6 months postprocedure. The type and duration of DAPT, stent(s) used, outcome, length of follow-up, complication rates, and incidence of significant in-stent stenosis (ISS) were collected. Results Of 556 patients reviewed, 450 met all inclusion criteria. Nine patients treated with DAPT 42 days after SAC did not reduce the risk of thrombotic complications or in-stent stenosis, although the risk of additional hemorrhagic complications remained low. It may be reasonable to discontinue DAPT after 42 days following non-flow diverting SAC of unruptured intracranial aneurysms.